特定组件的集群用于诊断和预测过敏呼吸道疾病
Rebecca Howard1, Sara Fontanella2, Angela Simpson1
1Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
概括
对成分特异性免疫球蛋白E (c-sIgE) 反应的详细分析显示,过敏原集群中的敏感化模式和数量预测过敏疾病风险. 这为喘和鼻炎提供了新的诊断和预后见解.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 计算生物学 计算生物学
背景情况:
- 机器学习已经确定了生物学上可信的过敏原成分集群.
- 对这些集群的敏感性与不同的临床结果相关.
研究的目的:
- 确定过敏原集群内敏感化的内部结构是否会影响过敏症状的临床表现.
- 研究成分特异性IgE (c-sIgE) 反应的数量和模式的作用.
主要方法:
- 利用基于人口的出生队列的数据,分析从婴儿到青春期的c-sIgE.
- 集群内定义的敏感化结构,包括c-sIgE反应数和敏感化模式.
- 采用后勤回归和双项通用添加模型来评估与喘和鼻炎的关联.
主要成果:
- 集群内敏感化模式显示了以前未被识别的与喘和鼻炎的联系.
- 详细的c-sIgE资料提供了新的诊断和预后信息.
- 5岁时群体内c-sIgE增加预测了5岁和16岁的喘患病率.
结论:
- 对集群内c-sIgE反应的详细描述为了解过敏性疾病提供了显著的附加值.
- 集群内c-sIgE反应的数量和模式对于风险评估至关重要.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.0K
07:52Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
Published on: July 23, 2012
15.0K
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Allergic Reactions
27.4K
Overview
27.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
